Regulatory Affairs Advisor
Liz is a specialist in international regulatory affairs with an extensive background in the biopharmaceutical industry, including 30 years’ experience of biotechnology and cell therapy products.
Liz worked initially for Celltech, and then for Amgen where she had overall project responsibility for a number of recombinant products in the area of haematology and oncology. She handled global development and registration strategies for biotechnology products in multiple therapeutic areas including oncology, nephrology, neurology, endocrinology and metabolism. The rapidly evolving regulatory environment in Europe and the US necessitated frequent in-depth contacts with regulators, which means she has established an extensive network across regulatory agencies and the industry. Since 1998 Liz has operated as both an independent or affiliated consultant offering strategic advice and practical assistance in the areas of drug development, clinical trials, regulatory affairs and product licensing to more than 50 different biopharmaceutical companies. She has been a member of the Immodulon Core Management Team since January 2009.